Ian F Parney Selected Research

Ian F Parney Research Topics

Disease

45	Neoplasms (Cancer) 01/2022 - 02/2002
33	Glioma (Gliomas) 01/2022 - 02/2002
30	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 02/2002
17	Brain Neoplasms (Brain Tumor) 09/2022 - 05/2002
4	Astrocytoma (Pilocytic Astrocytoma) 10/2014 - 11/2012
3	Neoplasm Metastasis (Metastasis) 09/2022 - 01/2017
3	Brain Injuries (Brain Injury) 01/2020 - 10/2013
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 10/2013
3	Melanoma (Melanoma, Malignant) 12/2016 - 05/2002
2	Medulloblastoma 01/2022 - 02/2014
2	Hemorrhage 01/2019 - 10/2018
2	Critical Illness (Critically Ill) 10/2013 - 10/2013
2	Inflammation (Inflammations) 10/2013 - 02/2002
1	Residual Neoplasm 01/2022
1	Uveal melanoma 10/2021
1	Primitive Neuroectodermal Tumors (PNET) 01/2021
1	Meningioma (Meningiomas) 09/2020
1	Acoustic Neuroma (Acoustic Neurinoma) 10/2019
1	Surgical Wound Infection 01/2019
1	Pulmonary Embolism 01/2019
1	Venous Thromboembolism 01/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2019
1	Postoperative Hemorrhage 01/2019
1	Infections 10/2018
1	Hematologic Neoplasms (Hematological Malignancy) 10/2018
1	Retinal Detachment (Retinal Detachments) 01/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2017
1	Macular Edema 01/2017
1	Brain Diseases (Brain Disorder) 01/2017
1	Neuroblastoma 04/2016

Drug/Important Bio-Agent (IBA)

10	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 09/2009
6	VaccinesIBA 01/2020 - 05/2002
6	AntigensIBA 01/2020 - 11/2011
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2003
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2005
4	Pharmaceutical PreparationsIBA 12/2021 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2018
3	Neoplasm Antigens (Tumor Antigens)IBA 04/2016 - 01/2003
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2006 - 05/2002
3	Interleukin-12 (IL 12)IBA 08/2002 - 02/2002
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 01/2019
2	Untranslated RNA (Noncoding RNA)IBA 01/2022 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 12/2021 - 01/2020
2	CarbonIBA 10/2021 - 12/2016
2	TensinsIBA 01/2020 - 01/2007
2	Biological ProductsIBA 01/2019 - 02/2005
2	Phenylalanine (L-Phenylalanine)FDA Link 05/2018 - 08/2013
2	GadoliniumIBA 01/2018 - 01/2015
2	Matrix Metalloproteinases (MMPs)IBA 10/2013 - 10/2013
2	CytokinesIBA 10/2013 - 02/2002
2	Amino Acids FDA Link 08/2013 - 01/2013
2	fluorodopa F 18IBA 08/2013 - 01/2013
2	InterleukinsIBA 02/2005 - 02/2002
1	MicroRNAs (MicroRNA)IBA 01/2022
1	dipinacoline glutamateIBA 01/2022
1	depatuxizumab mafodotinIBA 12/2021
1	Immunoconjugates (Immunoconjugate)IBA 12/2021
1	TantalumIBA 10/2021
1	Nylons (Nylon)IBA 10/2021
1	pembrolizumabIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	SteroidsIBA 12/2020
1	LuciferasesIBA 01/2020
1	LigandsIBA 01/2020
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020
1	Platelet-Derived Growth FactorIBA 01/2020
1	epidermal growth factor receptor VIIIIBA 01/2020
1	B7-H1 AntigenIBA 10/2019
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2019
1	pyrazoleIBA 01/2019
1	vinyltriethoxysilane (VTES)IBA 01/2019
1	Vancomycin FDA LinkGeneric 01/2019
1	InterferonsIBA 10/2018
1	Janus Kinase InhibitorsIBA 10/2018
1	Bevacizumab (Avastin)FDA Link 10/2018
1	ruxolitinibIBA 10/2018
1	SAR405838IBA 01/2018
1	Blocking AntibodiesIBA 01/2018
1	O-(6)-methylguanineIBA 10/2017
1	MethyltransferasesIBA 10/2017
1	sulforaphaneIBA 01/2017
1	Conditioned Culture MediaIBA 01/2017
1	O(6)-Methylguanine-DNA MethyltransferaseIBA 06/2016
1	Cytochromes c (Cytochrome c)IBA 04/2016

Therapy/Procedure

20	Therapeutics 09/2022 - 05/2002
15	Immunotherapy 01/2021 - 02/2002
14	Radiotherapy 10/2021 - 04/2007
6	Drug Therapy (Chemotherapy) 01/2022 - 05/2003
3	Craniotomy 01/2019 - 06/2003
2	Chemoradiotherapy 09/2009 - 08/2008
1	Lasers (Laser) 09/2022
1	Sutures (Suture) 10/2021
1	Adjuvant Radiotherapy 09/2020
1	Chemoprevention 01/2019
1	Length of Stay 10/2018
1	Reoperation 10/2018
1	Oncolytic Virotherapy 10/2018
1	Neurosurgical Procedures 01/2018
1	Traction 01/2017